Thymic and adenotonsillar enlargement after successful treatment of malignancies

Pediatric Hematology and Oncology

Volumn 22, Issue 5, 2005, Pages 423-435

  Oguz, Aynur ^a   Karadeniz, Ceyda ^a   Citak, Elvan Caglar ^a,b   Akyurek, Nalan ^a   Ileri, Fikret ^a   Boyunaga, Oznur ^a   Okur, Visal ^a   Uluoglu, Omer ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Department of Pathology ^*  (Turkey)

Author keywords

Adenotonsillar hyperplasia; Childhood; Malignant tumor; Thymic hyperplasia

Indexed keywords

ADENOID; ADENOID HYPERPLASIA; ADENOIDECTOMY; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; EWING SARCOMA; FEMALE; GERM CELL TUMOR; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; POLYCLONAL FOLLICULAR HYPERPLASIA; THYMUS; THYMUS HYPERPLASIA;

ADENOIDS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; THYMUS GLAND; TREATMENT OUTCOME;

EID: 22244448103     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010590964417     Document Type: Article

References (29)

1. Shin M, Ho K. Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin's disease. Cancer 1983;51:30-33.
2. Ford EG, Lockhart SK, Sullivan MP, Andrassy RJ. Mediastinal mass following chemotherapeutic treatment of Hodgkin's disease: recurrent tumour or thymic hyperplasia? J Pediatr Surg. 1987;22:1155-1159.
3. Carmosino L, DiBenedetto A, Feffer S. Thymic hyperplasia following successful chemotherapy. Cancer. 1985;56:1526-1528.
4. Mishra SK, Melinkeri SR, Dabadghao S. Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia. Eur J Haematol 2001;67:252-254.
5. Panadero MA, Cruz JJ, Gomez A, et al. Mediastinal mass following chemotherapy in patients with Ewing sarcoma and osteosarcoma. J Int Med. 1996;239:457-460.
6. Gelfland DW, Goldman AS, Law AJ. Thymic hyperplasia in children recovering from thermal burns. J Trauma. 1972;12:813-817.
7. Caffey J, Sibley R. Regrowth and overgrowth of the thymus after atrophy induced by oral administration of corticosteroids to human infants. Pediatrics. 1960;26:762-770.
8. Cohen M, Hill CA, Cangir A, Sullivan MP. Thymic rebound after treatment of childhood tumours. AJR 1980;135:151-156.
9. Feldges A, Wagner HP, Bubeck B, et al. Recurrent mediastinal mass in a child with Hodgkin's disease following successful therapy: a diagnostic challenge. Pediatr Surg Int. 1997;12:613-617.
10. Cumin I, Mechinaud F, Harousseau JL. Thymus hyperplasia following chemotherapy. Resse Med. 1996;25:291-292.
11. Minierro R, Busca A, Leonardo E, et al. Rebound thymic hyperplasia following high dose chemotherapy and allogeneic BMT Bone Marrow Transplant. 1993;11:67-70.
12. Henry K. The thymus gland. In: Systemic Pathology. Churchill-Livingstone. 1978;893-922.
13. Sloan HE. The thymus in myasthenia gravis. Surgery 1943;13:154-156.
14. Shinozuka H, Gill TJ 3rd, Kunz HW, Witkowski LA, Demetris AJ, Perara MIR. Cyclosporine enhances the induction of murine thymic lymphomas. Transplantation 1986;41:377-380.
15. Hattori A, Perara MIR, Witkowski LA, Kunz HW, Gill TJ 3rd, Shinokuza H. Accelerated development of spontaneous thymic lymphomas in male AKR mice receiving cyclosporine. Transplantation 1986;41:784-787.
16. Hattori A, Kuntz HW, Gill TJ, Shinokuza H. Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine. Am J Pathol. 1987;128:111-120.
17. Carmosino L, DiBenedetto A, Feffer S. Thymic hyperplasia following successful chemotherapy. Cancer. 1985;56:1526-1528.
18. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332:143-149.
19. Sperandio P, Tomio P, Oliver RT, Fiorentino MV, Pagano F. Gonodal atrophy as a cause of thymic hyperplasia after chemotherapy. Br J Cancer. 1996;74:991-992.
20. Heron CW, Husband JE, Williams MP. Hodgkin disease: CT of the thymus. Radiology. 1988;167:647-651.
21. Wernecke K, Vassallo P, Rutsch F, Peters PE, Potter R. Radiology. 1991;181:375-383.
22. Luker GD, Siegel MJ. Mediastinal Hodgkin disease in children: response to therapy. Radiology. 1993;189:737-740.
23. Suzuki K, Kurokawa K, Suzuki T, et al. Anterior mediastinal metastasis of testicular germ cell tumor: relation to benign thymic hyperplasia. Eur Urol 1997;32:37l-374.
24. Choyke PL, Zeman RK, Grootenberg JE, Greenberg JN, Hoffer F, Frank JA. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. AJR. 1987;149:269-272.
25. Hendriks JM, Van Schil PE, Schrijvers D, van mark E, Eyskens E. Rebound thymic hyperplasia after chemotherapy in a patient treated for pulmonary metastases. Acta Chir Belg. 1999;99:312-314.
26. Iosilevski G, Front D, Bettman L, et al. Uptake of 67Ga citrate and (2H-3) deoxyglucose in the tumor model, following chemotherapy and radiotherapy. J Nucl Med. 1985;26:278-284.
27. Israel O, Front D, Lam M, et al. Gallium-67 imaging in monitoring lymphoma response to treatment. Cancer. 1988;61:2439-2443.
28. Harris EW, Rakow JI, Weiner M, et al. Thallium-201 scintigraphy for a assessment of gallium-67-avid mediastinal mass following therapy for Hodgkin's disease. J Nucl Med. 1993;34:1326-1330.
29. Peylan-Ramu N, Hardy TB, Jones E. High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma. J Clin Oncol. 1989;7:1800-1806.